Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.78T
24h Vol:
$12.20B
Dominance:
MSFT:4.81%
Stocklytics Platform
Asset logo  GBIO
Generation Bio Co
GBIO
53 / 100
Penny Stock
$3.13arrow_drop_down7.12%-$0.24

Performance History

Stocklytics logo
Key Stats
Open$3.33
Prev. Close$3.39
EPS-2.55
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap234846656.00
PE Ratio-
LOWHIGH
Day Range3.19
3.39
52 Week Range0.86
6.98
Ratios
P/B Ratio1.21
Revenue$5.90M
Operating M. %-510.08%
Earnings$0.00
Earnings Growth %7.34%
EBITDA Margin %-1,000.00%
ROE %-82.24%
EPS-2.55

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$802.90
24H (%)arrow_drop_down0.03%
24H ($)-$0.26
MARKET CAP$744.33B
PRICE$521.34
24H (%)arrow_drop_down0.42%
24H ($)-$2.20
MARKET CAP$476.05B
PRICE$153.50
24H (%)arrow_drop_up1.49%
24H ($)$2.25
MARKET CAP$364.05B
PRICE$131.10
24H (%)arrow_drop_up0.26%
24H ($)$0.34
MARKET CAP$332.27B

About Generation Bio Co (GBIO)

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Cameron Geoffrey McDonough M.D.
Headquarters
Cambridge
Employees
150
Exchange
NASDAQ
add Generation Bio Co to watchlist

Keep an eye on Generation Bio Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Generation Bio Co's (GBIO) price per share?

The current price per share for Generation Bio Co (GBIO) is $3.37. The stock has seen a price change of -$0.02 recently, indicating a -0.59% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Generation Bio Co (GBIO)?

For Generation Bio Co (GBIO), the 52-week high is $6.98, which is 107.12% from the current price. The 52-week low is $0.86, the current price is 291.86% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Generation Bio Co (GBIO) a growth stock?

Generation Bio Co (GBIO) has shown an average price growth of 0.41% over the past three years. It has received a score of 7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Generation Bio Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Generation Bio Co (GBIO) stock price performance year to date (YTD)?

As of the latest data, Generation Bio Co (GBIO) has a year-to-date price change of 81.18%. Over the past month, the stock has experienced a price change of 19.93%. Over the last three months, the change has been 60.48%. Over the past six months, the figure is 193.04%.

help
Is Generation Bio Co (GBIO) a profitable company?

Generation Bio Co (GBIO) has a net income of -$126.61M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 10.86% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -510.08% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $5.9M, although specific revenue growth data is currently not available. The gross profit is $641K. Operating income is noted at -$138.56M. Furthermore, the EBITDA is -$119.16M.

help
What is the market capitalization of Generation Bio Co (GBIO)?

Generation Bio Co (GBIO) has a market capitalization of $234.85M. The average daily trading volume is 173.18K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level